Cell population addressed | Antigen | Clone | Isotype | Fluorochrome | Labelling strategy | Source of primary Ab |
---|---|---|---|---|---|---|
Myeloid cells, B cells and CD4+ T cells | CD3 | PPT3 | IgG1 | BV 421a | Biotin–streptavidin | In-house |
CD79α | HM57 | IgG1 | PE | Direct conjugation | Dako | |
 | CD172α | 74-22-15 | IgG1 | Alexa Fluor 647b | Direct conjugation | In-house |
CD4 | 74-12-4 | IgG2b | Alexa 488c | Secondary antibody | In-house | |
T cells and NK-cell subpopulations | CD3 | PPT3 | IgG1 | BV 421a | Biotin–streptavidin | In-house |
CD4 | 74-12-4 | IgG2b | Alexa Fluor 488c | Secondary antibody | In-house | |
CD8α | 11/295/33 | IgG2a | PEd | Secondary antibody | In-house | |
NKp46 | VIV-KM1 | IgG1 | Alexa Fluor 647b | Direct conjugation | In-house | |
γδ T-cell subpopulations | TCR-γδ | PPT16 | IgG2b | BV421a | Biotin–streptavidin | In-house |
CD8α | 11/295/33 | IgG2a | Alexa Fluor 647b | Direct conjugation | In-house | |
CD27 | b30c7 | IgG1 | PEe | Secondary antibody | In-house | |
CD2 | MSA4 | IgG2a | Alexa Fluor 488f | Direct conjugation | In-house |